Invitation to offer for NHS National Framework Agreement for the supply of Human Albumin and Human Anti-D Immunoglobulin
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £19,539,253 |
|---|---|
| Status | complete |
| Category (CPV) | 33141540 |
| Deadline | 31 Jan 2017 |
| Contract start | 1 May 2017 |
| Contract end | 30 Apr 2019 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-245e19b8-a706-44c8-8656-4fdb283c01e3 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| see attached | £21,139,266 | 3 Apr 2017 | active |
description
Invitation to offer for an NHS National Framework Agreement for the supply of Human Albumin and Human Anti-D Immunoglobulin. The period of the framework agreement will be 01.04.17 - 31.03.18 with options to extend for up to a further 36 months.
Please refer to Document No.05 for a list of purchasing points.
documents
- https://www.contractsfinder.service.gov.uk/Notice/737d17e9-f1cb-4ebf-9d77-739380712117 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/165c73d0-3ab7-40ab-a92d-d95d6d5ffe03 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ce58d657-6ad0-4050-a78e-17637ef0ae6b , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/ddaedeb0-c15c-4f3f-b389-2fa0fd833dde , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 19 Nov 2015 | Planning (planning) | · | ocds-b5fd17-03cedc23-adc9-11e6-9901-0019b9f3037b-80173-cm-phs-14-5438 |
| 17 Aug 2018 | Award update (awardUpdate) | · | 9a74264f-efa6-481d-aab9-5b97afde1478-235768 |
more from COMMERCIAL MEDICINES UNIT
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A. · £575,675,600 · 24 Apr 2017
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B · £102,379,487 · 24 Apr 2017
- Contract for the supply of BCG vaccine · 9 Jan 2017
- Contract for the supply of human papillomavrius vaccine · 22 Dec 2016
- NHS National Pharmaceuticals - Wave 10c Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months. Potential periods of call-offs under the framework agreement: Oral Products: All Regions 01/07/2017 to 28/02/2019 (20 months) Hospital Only Products: Central and South West (CESW) 01/07/2017 to 30/06/2018 (12 months); North West and Eastern and North London (NWLN) 01/07/2017 to 30/06/2018 (12 months) and South East and South London and North East and Yorkshire (LSNE) 01/07/2017 to 30/06/2018 (12 months) · £182,500,000 · 16 Dec 2016
- NHS Framework Agreement for Hepatitis C Medicines for Midlands and East and North of England regions · £85,000,000 · 25 Nov 2016
- Invitation to offer for NHS Framework Agreement for Branded Pharmaceuticals for London – Tranche A (inc. Hepatitis C) · £201,544,684 · 18 Nov 2016
- Contract for the supply of BCG vaccine · 18 Nov 2016
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Human Albumin · University Hospitals of Leicester NHS Trust · £518,438
- Human Albumin Solution · ST HELENS & KNOWSLEY TEACHING HOSPITALS NHS TRUST · £88,725
- NHS Framework Agreement for the supply of Human Albumin · The NHS Commissioning Board (operating under the name of NHS England)
- Albumin and Anti-D Immunoglobulin · Hull & East Yorkshire Hospitals Nhs Trust · £225,000
- SUPPLY OF HUMAN ALBUMIN SOLUTIONS · University Hospitals of North Midlands NHS Trust
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.